Global NeuN Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global NeuN Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 100

Published Date: 12 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The NeuN Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global NeuN Antibody size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global NeuN Antibody market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
NeuN Antibody market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Polyclonal
Monoclonal

Market segment by Application, can be divided into
Immunocytochemistry
Immunofluorescence
Immunohistochemistry
Western Blot
Others

Market segment by players, this report covers
Boster Biological Technology
Thermo Fisher Scientific
Abcam
HUABIO
Synaptic
GeneTex
BioLegend
Merck
NSJ Bioreagents
Bioss
Miltenyi Biotec
United States Biological
Proteintech
FineTest
Cell Signaling Technology

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe NeuN Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of NeuN Antibody, with revenue, gross margin and global market share of NeuN Antibody from 2019 to 2021.
Chapter 3, the NeuN Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and NeuN Antibody market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe NeuN Antibody research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of NeuN Antibody
1.2 Classification of NeuN Antibody by Type
1.2.1 Overview: Global NeuN Antibody Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NeuN Antibody Revenue Market Share by Type in 2020
1.2.3 Polyclonal
1.2.4 Monoclonal
1.3 Global NeuN Antibody Market by Application
1.3.1 Overview: Global NeuN Antibody Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunocytochemistry
1.3.3 Immunofluorescence
1.3.4 Immunohistochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Global NeuN Antibody Market Size & Forecast
1.5 Global NeuN Antibody Market Size and Forecast by Region
1.5.1 Global NeuN Antibody Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NeuN Antibody Market Size by Region, (2016-2021)
1.5.3 North America NeuN Antibody Market Size and Prospect (2016-2026)
1.5.4 Europe NeuN Antibody Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NeuN Antibody Market Size and Prospect (2016-2026)
1.5.6 South America NeuN Antibody Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NeuN Antibody Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NeuN Antibody Market Drivers
1.6.2 NeuN Antibody Market Restraints
1.6.3 NeuN Antibody Trends Analysis

2 Company Profiles
2.1 Boster Biological Technology
2.1.1 Boster Biological Technology Details
2.1.2 Boster Biological Technology Major Business
2.1.3 Boster Biological Technology NeuN Antibody Product and Solutions
2.1.4 Boster Biological Technology NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Boster Biological Technology Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific NeuN Antibody Product and Solutions
2.2.4 Thermo Fisher Scientific NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam NeuN Antibody Product and Solutions
2.3.4 Abcam NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abcam Recent Developments and Future Plans
2.4 HUABIO
2.4.1 HUABIO Details
2.4.2 HUABIO Major Business
2.4.3 HUABIO NeuN Antibody Product and Solutions
2.4.4 HUABIO NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 HUABIO Recent Developments and Future Plans
2.5 Synaptic
2.5.1 Synaptic Details
2.5.2 Synaptic Major Business
2.5.3 Synaptic NeuN Antibody Product and Solutions
2.5.4 Synaptic NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Synaptic Recent Developments and Future Plans
2.6 GeneTex
2.6.1 GeneTex Details
2.6.2 GeneTex Major Business
2.6.3 GeneTex NeuN Antibody Product and Solutions
2.6.4 GeneTex NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GeneTex Recent Developments and Future Plans
2.7 BioLegend
2.7.1 BioLegend Details
2.7.2 BioLegend Major Business
2.7.3 BioLegend NeuN Antibody Product and Solutions
2.7.4 BioLegend NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioLegend Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck NeuN Antibody Product and Solutions
2.8.4 Merck NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck Recent Developments and Future Plans
2.9 NSJ Bioreagents
2.9.1 NSJ Bioreagents Details
2.9.2 NSJ Bioreagents Major Business
2.9.3 NSJ Bioreagents NeuN Antibody Product and Solutions
2.9.4 NSJ Bioreagents NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 NSJ Bioreagents Recent Developments and Future Plans
2.10 Bioss
2.10.1 Bioss Details
2.10.2 Bioss Major Business
2.10.3 Bioss NeuN Antibody Product and Solutions
2.10.4 Bioss NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bioss Recent Developments and Future Plans
2.11 Miltenyi Biotec
2.11.1 Miltenyi Biotec Details
2.11.2 Miltenyi Biotec Major Business
2.11.3 Miltenyi Biotec NeuN Antibody Product and Solutions
2.11.4 Miltenyi Biotec NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Miltenyi Biotec Recent Developments and Future Plans
2.12 United States Biological
2.12.1 United States Biological Details
2.12.2 United States Biological Major Business
2.12.3 United States Biological NeuN Antibody Product and Solutions
2.12.4 United States Biological NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 United States Biological Recent Developments and Future Plans
2.13 Proteintech
2.13.1 Proteintech Details
2.13.2 Proteintech Major Business
2.13.3 Proteintech NeuN Antibody Product and Solutions
2.13.4 Proteintech NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Proteintech Recent Developments and Future Plans
2.14 FineTest
2.14.1 FineTest Details
2.14.2 FineTest Major Business
2.14.3 FineTest NeuN Antibody Product and Solutions
2.14.4 FineTest NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 FineTest Recent Developments and Future Plans
2.15 Cell Signaling Technology
2.15.1 Cell Signaling Technology Details
2.15.2 Cell Signaling Technology Major Business
2.15.3 Cell Signaling Technology NeuN Antibody Product and Solutions
2.15.4 Cell Signaling Technology NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Cell Signaling Technology Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global NeuN Antibody Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 NeuN Antibody Players Market Share
3.2.2 Top 10 NeuN Antibody Players Market Share
3.2.3 Market Competition Trend
3.3 NeuN Antibody Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global NeuN Antibody Revenue and Market Share by Type (2016-2021)
4.2 Global NeuN Antibody Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global NeuN Antibody Revenue Market Share by Application (2016-2021)
5.2 NeuN Antibody Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America NeuN Antibody Revenue by Type (2016-2026)
6.2 North America NeuN Antibody Revenue by Application (2016-2026)
6.3 North America NeuN Antibody Market Size by Country
6.3.1 North America NeuN Antibody Revenue by Country (2016-2026)
6.3.2 United States NeuN Antibody Market Size and Forecast (2016-2026)
6.3.3 Canada NeuN Antibody Market Size and Forecast (2016-2026)
6.3.4 Mexico NeuN Antibody Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe NeuN Antibody Revenue by Type (2016-2026)
7.2 Europe NeuN Antibody Revenue by Application (2016-2026)
7.3 Europe NeuN Antibody Market Size by Country
7.3.1 Europe NeuN Antibody Revenue by Country (2016-2026)
7.3.2 Germany NeuN Antibody Market Size and Forecast (2016-2026)
7.3.3 France NeuN Antibody Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NeuN Antibody Market Size and Forecast (2016-2026)
7.3.5 Russia NeuN Antibody Market Size and Forecast (2016-2026)
7.3.6 Italy NeuN Antibody Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NeuN Antibody Revenue by Type (2016-2026)
8.2 Asia-Pacific NeuN Antibody Revenue by Application (2016-2026)
8.3 Asia-Pacific NeuN Antibody Market Size by Region
8.3.1 Asia-Pacific NeuN Antibody Revenue by Region (2016-2026)
8.3.2 China NeuN Antibody Market Size and Forecast (2016-2026)
8.3.3 Japan NeuN Antibody Market Size and Forecast (2016-2026)
8.3.4 South Korea NeuN Antibody Market Size and Forecast (2016-2026)
8.3.5 India NeuN Antibody Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NeuN Antibody Market Size and Forecast (2016-2026)
8.3.7 Australia NeuN Antibody Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America NeuN Antibody Revenue by Type (2016-2026)
9.2 South America NeuN Antibody Revenue by Application (2016-2026)
9.3 South America NeuN Antibody Market Size by Country
9.3.1 South America NeuN Antibody Revenue by Country (2016-2026)
9.3.2 Brazil NeuN Antibody Market Size and Forecast (2016-2026)
9.3.3 Argentina NeuN Antibody Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NeuN Antibody Revenue by Type (2016-2026)
10.2 Middle East & Africa NeuN Antibody Revenue by Application (2016-2026)
10.3 Middle East & Africa NeuN Antibody Market Size by Country
10.3.1 Middle East & Africa NeuN Antibody Revenue by Country (2016-2026)
10.3.2 Turkey NeuN Antibody Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NeuN Antibody Market Size and Forecast (2016-2026)
10.3.4 UAE NeuN Antibody Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global NeuN Antibody Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global NeuN Antibody Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market NeuN Antibody Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global NeuN Antibody Revenue (USD Million) by Region (2016-2021)
Table 5. Global NeuN Antibody Revenue Market Share by Region (2021-2026)
Table 6. Boster Biological Technology Corporate Information, Head Office, and Major Competitors
Table 7. Boster Biological Technology Major Business
Table 8. Boster Biological Technology NeuN Antibody Product and Solutions
Table 9. Boster Biological Technology NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific NeuN Antibody Product and Solutions
Table 13. Thermo Fisher Scientific NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abcam Corporate Information, Head Office, and Major Competitors
Table 15. Abcam Major Business
Table 16. Abcam NeuN Antibody Product and Solutions
Table 17. Abcam NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. HUABIO Corporate Information, Head Office, and Major Competitors
Table 19. HUABIO Major Business
Table 20. HUABIO NeuN Antibody Product and Solutions
Table 21. HUABIO NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Synaptic Corporate Information, Head Office, and Major Competitors
Table 23. Synaptic Major Business
Table 24. Synaptic NeuN Antibody Product and Solutions
Table 25. Synaptic NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GeneTex Corporate Information, Head Office, and Major Competitors
Table 27. GeneTex Major Business
Table 28. GeneTex NeuN Antibody Product and Solutions
Table 29. GeneTex NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioLegend Corporate Information, Head Office, and Major Competitors
Table 31. BioLegend Major Business
Table 32. BioLegend NeuN Antibody Product and Solutions
Table 33. BioLegend NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck Corporate Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck NeuN Antibody Product and Solutions
Table 37. Merck NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. NSJ Bioreagents Corporate Information, Head Office, and Major Competitors
Table 39. NSJ Bioreagents Major Business
Table 40. NSJ Bioreagents NeuN Antibody Product and Solutions
Table 41. NSJ Bioreagents NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bioss Corporate Information, Head Office, and Major Competitors
Table 43. Bioss Major Business
Table 44. Bioss NeuN Antibody Product and Solutions
Table 45. Bioss NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 47. Miltenyi Biotec Major Business
Table 48. Miltenyi Biotec NeuN Antibody Product and Solutions
Table 49. Miltenyi Biotec NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. United States Biological Corporate Information, Head Office, and Major Competitors
Table 51. United States Biological Major Business
Table 52. United States Biological NeuN Antibody Product and Solutions
Table 53. United States Biological NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Proteintech Corporate Information, Head Office, and Major Competitors
Table 55. Proteintech Major Business
Table 56. Proteintech NeuN Antibody Product and Solutions
Table 57. Proteintech NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. FineTest Corporate Information, Head Office, and Major Competitors
Table 59. FineTest Major Business
Table 60. FineTest NeuN Antibody Product and Solutions
Table 61. FineTest NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Cell Signaling Technology Corporate Information, Head Office, and Major Competitors
Table 63. Cell Signaling Technology Major Business
Table 64. Cell Signaling Technology NeuN Antibody Product and Solutions
Table 65. Cell Signaling Technology NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global NeuN Antibody Revenue (USD Million) by Players (2019-2021)
Table 67. Global NeuN Antibody Revenue Share by Players (2019-2021)
Table 68. Breakdown of NeuN Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. NeuN Antibody Players Head Office, Products and Services Provided
Table 70. NeuN Antibody Mergers & Acquisitions in the Past Five Years
Table 71. NeuN Antibody New Entrants and Expansion Plans
Table 72. Global NeuN Antibody Revenue (USD Million) by Type (2016-2021)
Table 73. Global NeuN Antibody Revenue Share by Type (2016-2021)
Table 74. Global NeuN Antibody Revenue Forecast by Type (2021-2026)
Table 75. Global NeuN Antibody Revenue by Application (2016-2021)
Table 76. Global NeuN Antibody Revenue Forecast by Application (2021-2026)
Table 77. North America NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 78. North America NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 79. North America NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 80. North America NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 81. North America NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 82. North America NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific NeuN Antibody Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific NeuN Antibody Revenue by Region (2021-2026) & (USD Million)
Table 95. South America NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 96. South America NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 97. South America NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 98. South America NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 99. South America NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 100. South America NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. NeuN Antibody Picture
Figure 2. Global NeuN Antibody Revenue Market Share by Type in 2020
Figure 3. Polyclonal
Figure 4. Monoclonal
Figure 5. NeuN Antibody Revenue Market Share by Application in 2020
Figure 6. Immunocytochemistry Picture
Figure 7. Immunofluorescence Picture
Figure 8. Immunohistochemistry Picture
Figure 9. Western Blot Picture
Figure 10. Others Picture
Figure 11. Global NeuN Antibody Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global NeuN Antibody Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global NeuN Antibody Revenue Market Share by Region (2016-2026)
Figure 14. Global NeuN Antibody Revenue Market Share by Region in 2020
Figure 15. North America NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. NeuN Antibody Market Drivers
Figure 21. NeuN Antibody Market Restraints
Figure 22. NeuN Antibody Market Trends
Figure 23. Boster Biological Technology Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Abcam Recent Developments and Future Plans
Figure 26. HUABIO Recent Developments and Future Plans
Figure 27. Synaptic Recent Developments and Future Plans
Figure 28. GeneTex Recent Developments and Future Plans
Figure 29. BioLegend Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. NSJ Bioreagents Recent Developments and Future Plans
Figure 32. Bioss Recent Developments and Future Plans
Figure 33. Miltenyi Biotec Recent Developments and Future Plans
Figure 34. United States Biological Recent Developments and Future Plans
Figure 35. Proteintech Recent Developments and Future Plans
Figure 36. FineTest Recent Developments and Future Plans
Figure 37. Cell Signaling Technology Recent Developments and Future Plans
Figure 38. Global NeuN Antibody Revenue Share by Players in 2020
Figure 39. NeuN Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players NeuN Antibody Revenue Market Share in 2020
Figure 41. Global Top 10 Players NeuN Antibody Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global NeuN Antibody Revenue Share by Type in 2020
Figure 44. Global NeuN Antibody Market Share Forecast by Type (2021-2026)
Figure 45. Global NeuN Antibody Revenue Share by Application in 2020
Figure 46. Global NeuN Antibody Market Share Forecast by Application (2021-2026)
Figure 47. North America NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 48. North America NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 49. North America NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 50. United States NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 54. Europe NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 55. Europe NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 56. Germany NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific NeuN Antibody Revenue Market Share by Region (2016-2026)
Figure 64. China NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 71. South America NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 72. South America NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 73. Brazil NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 78. Turkey NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Boster Biological Technology
Thermo Fisher Scientific
Abcam
HUABIO
Synaptic
GeneTex
BioLegend
Merck
NSJ Bioreagents
Bioss
Miltenyi Biotec
United States Biological
Proteintech
FineTest
Cell Signaling Technology
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global NeuN Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global NeuN Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 100

Published Date: 12 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The NeuN Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global NeuN Antibody size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global NeuN Antibody market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
NeuN Antibody market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Polyclonal
Monoclonal

Market segment by Application, can be divided into
Immunocytochemistry
Immunofluorescence
Immunohistochemistry
Western Blot
Others

Market segment by players, this report covers
Boster Biological Technology
Thermo Fisher Scientific
Abcam
HUABIO
Synaptic
GeneTex
BioLegend
Merck
NSJ Bioreagents
Bioss
Miltenyi Biotec
United States Biological
Proteintech
FineTest
Cell Signaling Technology

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe NeuN Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of NeuN Antibody, with revenue, gross margin and global market share of NeuN Antibody from 2019 to 2021.
Chapter 3, the NeuN Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and NeuN Antibody market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe NeuN Antibody research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of NeuN Antibody
1.2 Classification of NeuN Antibody by Type
1.2.1 Overview: Global NeuN Antibody Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NeuN Antibody Revenue Market Share by Type in 2020
1.2.3 Polyclonal
1.2.4 Monoclonal
1.3 Global NeuN Antibody Market by Application
1.3.1 Overview: Global NeuN Antibody Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunocytochemistry
1.3.3 Immunofluorescence
1.3.4 Immunohistochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Global NeuN Antibody Market Size & Forecast
1.5 Global NeuN Antibody Market Size and Forecast by Region
1.5.1 Global NeuN Antibody Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NeuN Antibody Market Size by Region, (2016-2021)
1.5.3 North America NeuN Antibody Market Size and Prospect (2016-2026)
1.5.4 Europe NeuN Antibody Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NeuN Antibody Market Size and Prospect (2016-2026)
1.5.6 South America NeuN Antibody Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NeuN Antibody Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NeuN Antibody Market Drivers
1.6.2 NeuN Antibody Market Restraints
1.6.3 NeuN Antibody Trends Analysis

2 Company Profiles
2.1 Boster Biological Technology
2.1.1 Boster Biological Technology Details
2.1.2 Boster Biological Technology Major Business
2.1.3 Boster Biological Technology NeuN Antibody Product and Solutions
2.1.4 Boster Biological Technology NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Boster Biological Technology Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific NeuN Antibody Product and Solutions
2.2.4 Thermo Fisher Scientific NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam NeuN Antibody Product and Solutions
2.3.4 Abcam NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abcam Recent Developments and Future Plans
2.4 HUABIO
2.4.1 HUABIO Details
2.4.2 HUABIO Major Business
2.4.3 HUABIO NeuN Antibody Product and Solutions
2.4.4 HUABIO NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 HUABIO Recent Developments and Future Plans
2.5 Synaptic
2.5.1 Synaptic Details
2.5.2 Synaptic Major Business
2.5.3 Synaptic NeuN Antibody Product and Solutions
2.5.4 Synaptic NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Synaptic Recent Developments and Future Plans
2.6 GeneTex
2.6.1 GeneTex Details
2.6.2 GeneTex Major Business
2.6.3 GeneTex NeuN Antibody Product and Solutions
2.6.4 GeneTex NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GeneTex Recent Developments and Future Plans
2.7 BioLegend
2.7.1 BioLegend Details
2.7.2 BioLegend Major Business
2.7.3 BioLegend NeuN Antibody Product and Solutions
2.7.4 BioLegend NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioLegend Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck NeuN Antibody Product and Solutions
2.8.4 Merck NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck Recent Developments and Future Plans
2.9 NSJ Bioreagents
2.9.1 NSJ Bioreagents Details
2.9.2 NSJ Bioreagents Major Business
2.9.3 NSJ Bioreagents NeuN Antibody Product and Solutions
2.9.4 NSJ Bioreagents NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 NSJ Bioreagents Recent Developments and Future Plans
2.10 Bioss
2.10.1 Bioss Details
2.10.2 Bioss Major Business
2.10.3 Bioss NeuN Antibody Product and Solutions
2.10.4 Bioss NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bioss Recent Developments and Future Plans
2.11 Miltenyi Biotec
2.11.1 Miltenyi Biotec Details
2.11.2 Miltenyi Biotec Major Business
2.11.3 Miltenyi Biotec NeuN Antibody Product and Solutions
2.11.4 Miltenyi Biotec NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Miltenyi Biotec Recent Developments and Future Plans
2.12 United States Biological
2.12.1 United States Biological Details
2.12.2 United States Biological Major Business
2.12.3 United States Biological NeuN Antibody Product and Solutions
2.12.4 United States Biological NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 United States Biological Recent Developments and Future Plans
2.13 Proteintech
2.13.1 Proteintech Details
2.13.2 Proteintech Major Business
2.13.3 Proteintech NeuN Antibody Product and Solutions
2.13.4 Proteintech NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Proteintech Recent Developments and Future Plans
2.14 FineTest
2.14.1 FineTest Details
2.14.2 FineTest Major Business
2.14.3 FineTest NeuN Antibody Product and Solutions
2.14.4 FineTest NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 FineTest Recent Developments and Future Plans
2.15 Cell Signaling Technology
2.15.1 Cell Signaling Technology Details
2.15.2 Cell Signaling Technology Major Business
2.15.3 Cell Signaling Technology NeuN Antibody Product and Solutions
2.15.4 Cell Signaling Technology NeuN Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Cell Signaling Technology Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global NeuN Antibody Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 NeuN Antibody Players Market Share
3.2.2 Top 10 NeuN Antibody Players Market Share
3.2.3 Market Competition Trend
3.3 NeuN Antibody Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global NeuN Antibody Revenue and Market Share by Type (2016-2021)
4.2 Global NeuN Antibody Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global NeuN Antibody Revenue Market Share by Application (2016-2021)
5.2 NeuN Antibody Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America NeuN Antibody Revenue by Type (2016-2026)
6.2 North America NeuN Antibody Revenue by Application (2016-2026)
6.3 North America NeuN Antibody Market Size by Country
6.3.1 North America NeuN Antibody Revenue by Country (2016-2026)
6.3.2 United States NeuN Antibody Market Size and Forecast (2016-2026)
6.3.3 Canada NeuN Antibody Market Size and Forecast (2016-2026)
6.3.4 Mexico NeuN Antibody Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe NeuN Antibody Revenue by Type (2016-2026)
7.2 Europe NeuN Antibody Revenue by Application (2016-2026)
7.3 Europe NeuN Antibody Market Size by Country
7.3.1 Europe NeuN Antibody Revenue by Country (2016-2026)
7.3.2 Germany NeuN Antibody Market Size and Forecast (2016-2026)
7.3.3 France NeuN Antibody Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NeuN Antibody Market Size and Forecast (2016-2026)
7.3.5 Russia NeuN Antibody Market Size and Forecast (2016-2026)
7.3.6 Italy NeuN Antibody Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NeuN Antibody Revenue by Type (2016-2026)
8.2 Asia-Pacific NeuN Antibody Revenue by Application (2016-2026)
8.3 Asia-Pacific NeuN Antibody Market Size by Region
8.3.1 Asia-Pacific NeuN Antibody Revenue by Region (2016-2026)
8.3.2 China NeuN Antibody Market Size and Forecast (2016-2026)
8.3.3 Japan NeuN Antibody Market Size and Forecast (2016-2026)
8.3.4 South Korea NeuN Antibody Market Size and Forecast (2016-2026)
8.3.5 India NeuN Antibody Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NeuN Antibody Market Size and Forecast (2016-2026)
8.3.7 Australia NeuN Antibody Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America NeuN Antibody Revenue by Type (2016-2026)
9.2 South America NeuN Antibody Revenue by Application (2016-2026)
9.3 South America NeuN Antibody Market Size by Country
9.3.1 South America NeuN Antibody Revenue by Country (2016-2026)
9.3.2 Brazil NeuN Antibody Market Size and Forecast (2016-2026)
9.3.3 Argentina NeuN Antibody Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NeuN Antibody Revenue by Type (2016-2026)
10.2 Middle East & Africa NeuN Antibody Revenue by Application (2016-2026)
10.3 Middle East & Africa NeuN Antibody Market Size by Country
10.3.1 Middle East & Africa NeuN Antibody Revenue by Country (2016-2026)
10.3.2 Turkey NeuN Antibody Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NeuN Antibody Market Size and Forecast (2016-2026)
10.3.4 UAE NeuN Antibody Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global NeuN Antibody Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global NeuN Antibody Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market NeuN Antibody Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global NeuN Antibody Revenue (USD Million) by Region (2016-2021)
Table 5. Global NeuN Antibody Revenue Market Share by Region (2021-2026)
Table 6. Boster Biological Technology Corporate Information, Head Office, and Major Competitors
Table 7. Boster Biological Technology Major Business
Table 8. Boster Biological Technology NeuN Antibody Product and Solutions
Table 9. Boster Biological Technology NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific NeuN Antibody Product and Solutions
Table 13. Thermo Fisher Scientific NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abcam Corporate Information, Head Office, and Major Competitors
Table 15. Abcam Major Business
Table 16. Abcam NeuN Antibody Product and Solutions
Table 17. Abcam NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. HUABIO Corporate Information, Head Office, and Major Competitors
Table 19. HUABIO Major Business
Table 20. HUABIO NeuN Antibody Product and Solutions
Table 21. HUABIO NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Synaptic Corporate Information, Head Office, and Major Competitors
Table 23. Synaptic Major Business
Table 24. Synaptic NeuN Antibody Product and Solutions
Table 25. Synaptic NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GeneTex Corporate Information, Head Office, and Major Competitors
Table 27. GeneTex Major Business
Table 28. GeneTex NeuN Antibody Product and Solutions
Table 29. GeneTex NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioLegend Corporate Information, Head Office, and Major Competitors
Table 31. BioLegend Major Business
Table 32. BioLegend NeuN Antibody Product and Solutions
Table 33. BioLegend NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck Corporate Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck NeuN Antibody Product and Solutions
Table 37. Merck NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. NSJ Bioreagents Corporate Information, Head Office, and Major Competitors
Table 39. NSJ Bioreagents Major Business
Table 40. NSJ Bioreagents NeuN Antibody Product and Solutions
Table 41. NSJ Bioreagents NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bioss Corporate Information, Head Office, and Major Competitors
Table 43. Bioss Major Business
Table 44. Bioss NeuN Antibody Product and Solutions
Table 45. Bioss NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 47. Miltenyi Biotec Major Business
Table 48. Miltenyi Biotec NeuN Antibody Product and Solutions
Table 49. Miltenyi Biotec NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. United States Biological Corporate Information, Head Office, and Major Competitors
Table 51. United States Biological Major Business
Table 52. United States Biological NeuN Antibody Product and Solutions
Table 53. United States Biological NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Proteintech Corporate Information, Head Office, and Major Competitors
Table 55. Proteintech Major Business
Table 56. Proteintech NeuN Antibody Product and Solutions
Table 57. Proteintech NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. FineTest Corporate Information, Head Office, and Major Competitors
Table 59. FineTest Major Business
Table 60. FineTest NeuN Antibody Product and Solutions
Table 61. FineTest NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Cell Signaling Technology Corporate Information, Head Office, and Major Competitors
Table 63. Cell Signaling Technology Major Business
Table 64. Cell Signaling Technology NeuN Antibody Product and Solutions
Table 65. Cell Signaling Technology NeuN Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global NeuN Antibody Revenue (USD Million) by Players (2019-2021)
Table 67. Global NeuN Antibody Revenue Share by Players (2019-2021)
Table 68. Breakdown of NeuN Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. NeuN Antibody Players Head Office, Products and Services Provided
Table 70. NeuN Antibody Mergers & Acquisitions in the Past Five Years
Table 71. NeuN Antibody New Entrants and Expansion Plans
Table 72. Global NeuN Antibody Revenue (USD Million) by Type (2016-2021)
Table 73. Global NeuN Antibody Revenue Share by Type (2016-2021)
Table 74. Global NeuN Antibody Revenue Forecast by Type (2021-2026)
Table 75. Global NeuN Antibody Revenue by Application (2016-2021)
Table 76. Global NeuN Antibody Revenue Forecast by Application (2021-2026)
Table 77. North America NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 78. North America NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 79. North America NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 80. North America NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 81. North America NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 82. North America NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific NeuN Antibody Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific NeuN Antibody Revenue by Region (2021-2026) & (USD Million)
Table 95. South America NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 96. South America NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 97. South America NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 98. South America NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 99. South America NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 100. South America NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa NeuN Antibody Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa NeuN Antibody Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa NeuN Antibody Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa NeuN Antibody Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa NeuN Antibody Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa NeuN Antibody Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. NeuN Antibody Picture
Figure 2. Global NeuN Antibody Revenue Market Share by Type in 2020
Figure 3. Polyclonal
Figure 4. Monoclonal
Figure 5. NeuN Antibody Revenue Market Share by Application in 2020
Figure 6. Immunocytochemistry Picture
Figure 7. Immunofluorescence Picture
Figure 8. Immunohistochemistry Picture
Figure 9. Western Blot Picture
Figure 10. Others Picture
Figure 11. Global NeuN Antibody Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global NeuN Antibody Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global NeuN Antibody Revenue Market Share by Region (2016-2026)
Figure 14. Global NeuN Antibody Revenue Market Share by Region in 2020
Figure 15. North America NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa NeuN Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. NeuN Antibody Market Drivers
Figure 21. NeuN Antibody Market Restraints
Figure 22. NeuN Antibody Market Trends
Figure 23. Boster Biological Technology Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Abcam Recent Developments and Future Plans
Figure 26. HUABIO Recent Developments and Future Plans
Figure 27. Synaptic Recent Developments and Future Plans
Figure 28. GeneTex Recent Developments and Future Plans
Figure 29. BioLegend Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. NSJ Bioreagents Recent Developments and Future Plans
Figure 32. Bioss Recent Developments and Future Plans
Figure 33. Miltenyi Biotec Recent Developments and Future Plans
Figure 34. United States Biological Recent Developments and Future Plans
Figure 35. Proteintech Recent Developments and Future Plans
Figure 36. FineTest Recent Developments and Future Plans
Figure 37. Cell Signaling Technology Recent Developments and Future Plans
Figure 38. Global NeuN Antibody Revenue Share by Players in 2020
Figure 39. NeuN Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players NeuN Antibody Revenue Market Share in 2020
Figure 41. Global Top 10 Players NeuN Antibody Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global NeuN Antibody Revenue Share by Type in 2020
Figure 44. Global NeuN Antibody Market Share Forecast by Type (2021-2026)
Figure 45. Global NeuN Antibody Revenue Share by Application in 2020
Figure 46. Global NeuN Antibody Market Share Forecast by Application (2021-2026)
Figure 47. North America NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 48. North America NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 49. North America NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 50. United States NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 54. Europe NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 55. Europe NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 56. Germany NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific NeuN Antibody Revenue Market Share by Region (2016-2026)
Figure 64. China NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 71. South America NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 72. South America NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 73. Brazil NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa NeuN Antibody Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa NeuN Antibody Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa NeuN Antibody Revenue Market Share by Country (2016-2026)
Figure 78. Turkey NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE NeuN Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Boster Biological Technology
Thermo Fisher Scientific
Abcam
HUABIO
Synaptic
GeneTex
BioLegend
Merck
NSJ Bioreagents
Bioss
Miltenyi Biotec
United States Biological
Proteintech
FineTest
Cell Signaling Technology
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now